[vc_row][vc_column width=”1/4″][vc_column_text]
Dr
Dr Detlev Boison
[/vc_column_text][/vc_column][vc_column width=”1/2″][vc_tta_tabs style=”modern” color=”white” active_section=”1″][vc_tta_section title=”About Speaker” tab_id=”1493848067536-ce786fab-b61e”][vc_column_text]Having a passion for translational research and for finding cures for intractable conditions that cause human suffrage and death, I seek to translate fundamental mechanisms of biochemistry and energy homeostasis into novel therapeutic approaches for the treatment of neurological and psychiatric conditions and cancer. A major research effort is the development of therapies that restore the equilibrium of adenosine and associated epigenetic changes and thereby reset the ‘disease clock’.
I graduated at the University of Köln, Germany, in 1994 with a PhD in Biochemistry. In 1995 I started my independent research career at the University and Federal Institute of Technology in Zürich where I received the venia legendi in Cellular Pharmacology in 2005 for my work on cell-based adenosine augmentation therapies for epilepsy. That same year I joined Legacy Health in Portland, Oregon, where I am currently Chair and Director of the Robert Stone Dow Neurobiology Laboratories, Co-Director of the Wayne D. Kuni & Joan E. Kuni Cancer Research Laboratory, and Director of Basic and Translational Research of the Legacy Research Institute. In addition, I hold faculty appointments at Oregon Health and Science University and at Washington State University.
I have published over 140 papers with an h-index of 46 and have delivered over 120 lectures in more than 20 different countries.[/vc_column_text][/vc_tta_section][vc_tta_section title=”Speaker Topic” tab_id=”1493848067788-b21528f0-e270″][vc_column_text]How does the ketogenic diet help our mood.[/vc_column_text][/vc_tta_section][/vc_tta_tabs][/vc_column][vc_column width=”1/4″ css=”.vc_custom_1520681849793{background-color: #d8d8d8 !important;}”][vc_widget_sidebar sidebar_id=”summit-sidebar-2″][/vc_column][/vc_row]
